Product Information
CREON DR 6,000 UNIT CAPSULE is a brand product labeled by AbbVie Inc., priced at $2.1049 per EA under NDC 00032120601. Its NADAC has been published 671 times since Nov 28, 2013.
Strength
30000; 6000; 19000 [USP'U]/1; [USP'U]/1; [USP'U]/1
Manufacturer
AbbVie Inc.NDC
00032120601
Classification
Brand
Dosage Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASEApproval Type
Biologic (BLA)
FDA Application
BLA020725On Market Since
4/30/2009
Price Statistics
The NADAC for CREON DR 6,000 UNIT CAPSULE has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 99.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1049 per EA |
|---|---|
| All-time high | $2.1107 (May 13, 2026) |
| All-time low | $1.0488 (Dec 18, 2013) |
| 52-week high | $2.1107 |
| 52-week low | $2.0568 |
| Median price | $1.6061 |
| Average price | $1.6021 |
| Largest weekly change | +7.4% (Jan 8, 2020) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AbbVie Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pancrelipase market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CREON DR 6,000 UNIT CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CREON DR 6,000 UNIT CAPSULE, manufactured by AbbVie Inc., is $2.1049 per EA (NDC 00032120601), effective Sep 30, 2026.
How has the price of CREON DR 6,000 UNIT CAPSULE changed over time?
Over the history we have for it, the NADAC for CREON DR 6,000 UNIT CAPSULE has risen 99.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CREON DR 6,000 UNIT CAPSULE?
Since Nov 28, 2013, the NADAC for CREON DR 6,000 UNIT CAPSULE has ranged from a low of $1.0488 (Dec 18, 2013) to a high of $2.1107 (May 13, 2026), with a median of $1.6061 per EA.
Are there cheaper alternatives to CREON DR 6,000 UNIT CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CREON DR 6,000 UNIT CAPSULE, is $1.9927 per EA — about 5% below CREON DR 6,000 UNIT CAPSULE.
Who manufactures CREON DR 6,000 UNIT CAPSULE?
CREON DR 6,000 UNIT CAPSULE (NDC 00032120601) is labeled by AbbVie Inc., and CMS classifies it as a brand product.